Literature DB >> 19938084

"It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.

Alison D Archibald1, Alice M Jaques, Samantha Wake, Veronica R Collins, Jonathan Cohen, Sylvia A Metcalfe.   

Abstract

Population carrier screening for fragile X syndrome can provide women with information about their risk of having a child with fragile X syndrome and their risk of fragile X-associated primary ovarian insufficiency and fragile X-associated tremor ataxia syndrome. Few studies have explored women's decisions when offered carrier screening for fragile X syndrome. Interviews were conducted with 31 women who participated in a pilot study offering carrier screening to non-pregnant women. A qualitative approach was used to gain an in-depth understanding of women's experiences and examine their decision-making processes, including women who were tested and those who decided not to be tested. The decision-making process occurred in two phases. In the first phase, the participant's reproductive stage of life and experience with illness and disability were major factors influencing whether she would consider screening. In the second phase of decision-making, participants' perceptions of the value of knowing their carrier status was the most notable factor for influencing whether a woman actually had the carrier test. Some women appreciated having time for deliberation and those who were tested did not express regret about their decision. Our findings support offering carrier screening for fragile X syndrome to non-pregnant women and suggest that women from the general population will have specific informational and counseling needs when offered carrier testing. This study highlights the unique challenges encountered by women from the general population when making a decision about testing for fragile X syndrome carrier status and illustrates the importance of understanding how women make decisions.

Entities:  

Mesh:

Year:  2009        PMID: 19938084     DOI: 10.1002/ajmg.a.33122

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

1.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

2.  Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making.

Authors:  Alison D Archibald; Belinda J McClaren
Journal:  J Community Genet       Date:  2011-11-17

Review 3.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

4.  "It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare.

Authors:  Alison D Archibald; Chriselle L Hickerton; Samantha A Wake; Alice M Jaques; Jonathan Cohen; Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2016-02-03

Review 5.  Measuring informed choice in population-based reproductive genetic screening: a systematic review.

Authors:  Alice Grace Ames; Sylvia Ann Metcalfe; Alison Dalton Archibald; Rony Emily Duncan; Jon Emery
Journal:  Eur J Hum Genet       Date:  2014-05-21       Impact factor: 4.246

6.  Family Communication and Cascade Testing for Fragile X Syndrome.

Authors:  Melissa Raspa; Anne Edwards; Anne C Wheeler; Ellen Bishop; Donald B Bailey
Journal:  J Genet Couns       Date:  2016-03-09       Impact factor: 2.537

7.  A tailored approach to family-centered genetic counseling for cystic fibrosis newborn screening: the Wisconsin model.

Authors:  Audrey Tluczek; Christina Zaleski; Dania Stachiw-Hietpas; Peggy Modaff; Craig R Adamski; Megan R Nelson; Catherine A Reiser; Sumedha Ghate; Kevin D Josephson
Journal:  J Genet Couns       Date:  2010-10-09       Impact factor: 2.537

8.  Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.

Authors:  Alice G Ames; Alice Jaques; Obioha C Ukoumunne; Alison D Archibald; Rony E Duncan; Jon Emery; Sylvia A Metcalfe
Journal:  Health Expect       Date:  2012-10-15       Impact factor: 3.377

9.  Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening.

Authors:  Sylvia A Metcalfe; Melissa Martyn; Alice Ames; Vicki Anderson; Alison D Archibald; Grad Dip Gen Couns; Rob Carter; Jonathan Cohen; Megan Cotter; M GenCouns; William Dang; Martin B Delatycki; Susan Donath; Samantha Edwards; PGrad Dip Educ; Grad Dip Gen Couns; Robin Forbes; Grad Dip Gen Couns; Mioara Gavrila; M MedSci; Jane Halliday; Chriselle Hickerton; Melissa Hill; Grad Dip Gen Couns; Lorilli Jacobs; PGrad Dip Ultrasound; Vicki Petrou; Grad Dip Gen Couns; Loren Plunkett; M GenCouns; Leslie Sheffield; F Racp; Alison Thornton; Grad Dip Gen Couns; Sandra Younie; PGrad Dip Hlth Econ; Jon D Emery
Journal:  Genet Med       Date:  2017-06-29       Impact factor: 8.822

10.  Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population.

Authors:  Thirsa Conijn; Ivy van Dijke; Lotte Haverman; Phillis Lakeman; Frits A Wijburg; Lidewij Henneman
Journal:  J Community Genet       Date:  2021-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.